“…The complement molecules modulate systemic inflammatory responses through communication with the pituitary gland (Francis et al, 2003). However, CFH is associated with neurodegenerative diseases, decreased risk of recurrent pregnancy loss, periodontitis, myocardial infarction (MI), and a smoking-related risk factor for lung cancer (Cho et al, 2019;Ezzeldin et al, 2015;Kardys et al, 2007;Maugeri et al, 2019;Salminen et al, 2022;Zhang et al, 2016). A study done by Zhang et al showed that CFH rs1061170 has strong associations with Alzheimer's disease (AD) in the European population and Han Chinese and European populations together (p < 0.001, p meta = 0.0005, respectively) (Zhang et al, 2016) Abbreviations: AIC, akaike information criterion; OR, odds ratio; PA, pituitary adenoma; p-value, significance level (differences considered significant when p < 0.05).…”